Sep 12, 2023 9:00 am EDT BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
Sep 8, 2023 8:30 am EDT BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
Jun 27, 2023 7:00 am EDT BioRestorative Therapies Receives Unanimous Recommendation from Data Safety Monitoring Board (DSMB) to Continue its Phase 2 Clinical Trial without any Changes
Jun 16, 2023 7:00 am EDT BioRestorative Therapies, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET
Jun 12, 2023 7:00 am EDT BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
Jun 1, 2023 9:15 am EDT BioRestorative Therapies, Inc. to attend the Jefferies 2023 Healthcare Conference
May 31, 2023 7:00 am EDT BioRestorative Therapies Receives License from New York State Department of Health to act as Tissue Bank for Mesenchymal Stem Cell Processing
May 15, 2023 7:00 am EDT BioRestorative Therapies Receives Notice of Allowance by the Japanese Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program
May 8, 2023 7:00 am EDT BioRestorative Therapies and Northwell Health Enter into Agreement to Participate in the Company’s Phase 2 Clinical Trial